Indivior PLC (LON:INDV – Get Free Report) passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of GBX 1,238 and traded as high as GBX 1,264. Indivior shares last traded at GBX 1,238, with a volume of 8,457,898 shares traded.
Indivior Price Performance
The company has a debt-to-equity ratio of -170.06, a current ratio of 0.83 and a quick ratio of 1.52. The company has a market cap of £1.93 billion, a PE ratio of -1,026.48, a P/E/G ratio of -5.57 and a beta of 0.19. The company has a 50-day moving average price of GBX 1,238 and a two-hundred day moving average price of GBX 1,154.92.
Indivior Company Profile
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Read More
- Five stocks we like better than Indivior
- What Makes a Stock a Good Dividend Stock?
- Keysight Technologies’ Surge: The Market Wakes Up to This AI Play
- Asset Allocation Strategies in Volatile Markets
- Is American Express the Credit Stock For a K-Shaped Economy?
- Using the MarketBeat Dividend Tax Calculator
- Powering Up: How a Credit Upgrade Fuels Vistra’s AI Ambitions
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.
